BSE has listed 2,79,000 new equity shares of Shelter Pharma Limited (Scrip Code: 543963) for trading effective Thursday, May 7, 2026. The shares were issued on a preferential basis to Non-Promoters at Rs. 42.25/- per share (face value Rs. 10/- + premium Rs. 32.25/-) pursuant to conversion of warrants.

Key Points

• 2,79,000 equity shares of Rs. 10/- each issued at a premium of Rs. 32.25/- per share
• Issue price: Rs. 42.25/- per share
• Issued to Non-Promoters on preferential basis via warrant conversion
• Shares rank pari-passu with existing equity shares
• ISIN: INE013V01011
• Distribution numbers: 16332793 to 16611792

Regulatory Changes

No regulatory changes. This is a routine listing notice for newly issued securities.

Compliance Requirements

• Trading members are informed that these securities are now listed and permitted to trade on BSE from May 7, 2026
• Lock-in applies to all 2,79,000 shares (Dist. Nos. 16332793–16611792) until November 15, 2026

Important Dates

• Date of Allotment: March 7, 2026
• Trading effective from: May 7, 2026
• Lock-in period ends: November 15, 2026

Impact Assessment

This is a routine listing of newly allotted shares from warrant conversion. The addition of 2,79,000 shares is a minor dilution event for Shelter Pharma Limited. All new shares are under lock-in until November 15, 2026, limiting immediate selling pressure. Broader market impact is negligible.